Novel Membership Model Continues to Take Shape
 
Institutional members, as represented by individual investigators, form the core of the ECOG-ACRIN organization and its scientific programs. As the Group obtains more information about the National Cancer Institute guidelines for membership in its National Clinical Trials Network, it continues to make progress in the development of its membership program.

  

ECOG-ACRIN has established a guiding principle for the development of its membership model: parity in trial accrual and scientific engagement is essential. This unique approach to membership, currently in development, is designed to fully support the expanded membership base and provide continuity to all incoming institutions and individuals with a history of participation in either ECOG or ACRIN.  

 

Several membership classifications have been designed to include varying levels of interaction and commitment from institutions and their investigators. More information is now available in the new Membership section on the ECOG-ACRIN website.

Did you know that the two legacy groups had very different models for institutional participation? Visit the Membership Model page for information on their integration.
  
More Than 70 Institutions Soon to Become Main Members of ECOG-ACRIN 
 
Main Members comprise institutions with ongoing sustained involvement in ECOG-ACRIN. More than 70 institutions with a history of participation in the Group will soon be transitioned to the Main Member classification.  
 
The Main Member classification consists of cancer centers, university medical centers, health systems, and community hospitals. The classification also includes National Cancer Institute-funded Community Cancer Oncology Programs (CCOPs) and Minority-Based CCOPs that have designated the ECOG-ACRIN Cancer Research Group as a primary research base.

 

ECOG-ACRIN has Main Members in the United States, Ireland, and Peru.

 

Institutions have different research capabilities, and investigators have different objectives. It is for this reason that the Group lends equal support to two important roles of institutional membership: trial accrual and scientific engagement. As a result, the Group has established two types of Main Members: Standing Main Members and Scientific Main Members

 

The ECOG-ACRIN website was updated this week to include information about Main Members
  
ECOG-ACRIN Completes the Formation of Its Three Scientific Programs  

ECOG-ACRIN has boldly integrated its diverse membership, which has broad experience in translational science; therapeutic, diagnostic imaging, cancer control, and patient-centered outcomes; and statistical and bioinformatics-based disciplines, into a single organization. This integration provides an exciting multidisciplinary environment in which to achieve patient-centered research advancements across the cancer care continuum, from prevention through treatment of advanced disease.

 

Group science emanates from integral, interrelated interactions across these three programs.

  

To leverage these capabilities most effectively, ECOG-ACRIN has established three methodology-based scientific programs for the formal organization of its research activities: Cancer Control and OutcomesTherapeutic Studies, and Biomarker Sciences. Group science emanates from integral, interrelated interactions across these three programs. 

 

The ECOG-ACRIN website was updated last week to include an overview of the Scientific Programs

  
Q and A with Dr. Schneider
 
 

Bryan_Schneider 

Bryan P. Schneider, MD, recipient of the 2012 Young Investigator Award from the ECOG Research and Education Foundation, gave the keynote presentation--Breast Cancer Genomics and Pharmacogenomics: Making it Personal--at the General Session of the ECOG-ACRIN Fall 2012 Group Meeting.

 

We recently caught up with Dr. Schneider and asked him to recap his presentation for our members who may have missed it.

 

Read more...

  
Dr. Khuri to Receive Honor From AACR
 
Faldo_Khuri
 
Fadlo R. Khuri, MD, Chair of the ECOG-ACRIN Early Detection, Diagnosis, and Prevention Committee, will receive the 2013 Richard and Hinda Rosenthal Award from the American Association for Cancer Research (AACR) at its upcoming annual meeting in Washington, DC. 
 
 
Dr. Khuri is Professor and Chair of Hematology/Oncology at the Emory University School of Medicine and Deputy Director of the Winship Cancer Institute of Emory University. 
 
Dr. Khuri will deliver his award lecture--Targeting Survival Signaling in Aerodigestive Cancers--at the AACR Annual Meeting 2013 in Washington, DC. The award ceremony and lecture will be held Wednesday, April 10, 2013 from 10:00 to 11:00 AM
 
The award recognizes individuals younger than 50 years of age for research that has made, or promises to soon make, a notable contribution to improved clinical care in the field of cancer. 

March 2013
In This Issue
Membership Takes Shape
ECOG-ACRIN's Main Members
Scientific Programs Formed
Q and A with Dr. Schneider
AACR Honors Dr. Khuri
Latest Group Meeting Info
Recognitions and Distinctions
Nominate Young Investigators
Oncology Fellows, Apply Now!
Spring 2013 Group Meeting

Attendees: Please note the new Thursday to Saturday format before making travel plans.
 
11:00 AM Thursday, May 16 through 
12:00 PM Saturday, May 18 
 
Location: Atlanta, GA

Visit the Registration Website for the latest schedule and other meeting information.
 
Recognitions and Distinctions
 
Congratulations to lead author Leo I. Gordon, MD, FACP, and coauthors of the recently published E2496 study results. In February 2013, their paper was the most accessed original report in the Journal of Clinical Oncology.  

 

The report, entitled "Randomized Phase III Trial of ABVD Versus Stanford V with or without Radiation Therapy in Locally Extensive and Advanced-stage Hodgkin Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperative Oncology Group (E2496)," was published online November 26, 2012.

 

View the abstract...

Attention Principal Investigators:

Your nominations for the 2013 Young Investigator Award are due by April 19, 2013.

 
Oncology Fellows: Applications Due!

Applications for the 2013 Paul Carbone, MD Fellowship Award are being accepted through April 5, 2013.

 
Would you like to receive future 
newsletters via your email inbox?

newsletter sign up
    
    Visit the site:
 
logo link to site 
 
 
 
 
 
Have a suggestion for a future newsletter topic?
  

  

ECOG-ACRIN Cancer Research Group  |  Office of Communications
 1818 Market Street, Suite 1100, Philadelphia, PA 19103 | (215) 789-3631